Skip to content

Veri-Q Self-Testing and Veri-Q Plus Mgd-2001 Blood Glucose Monitoring Systems

by Mico Biomed Co., Ltd.

510(k) K123016

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK123016 Date18 Jun 2013ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
NBW
Device Class
Class II
Regulation
21 CFR Part 862.1345
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The VERI-Q MGD-2001 Blood Glucose Monitoring System is an in vitro diagnostic device designed for self-testing blood glucose levels outside the body. It is classified as a blood glucose test system and intended for use by individuals with diabetes to monitor their glucose levels at home. The system provides results to aid in managing diabetes control through regular self-monitoring.

This device is supplied as a reusable monitoring system with disposable test strips and lancets. It has received FDA 510(k) clearance under the product code NBW, classified as a Class II device under special controls. The system is intended for over-the-counter use and was determined to be substantially equivalent to a predicate device. No specific sterility or MRI safety information is provided in the available data.

Other devices from Mico Biomed Co., Ltd.

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the VERI-Q MGD-2001 Blood Glucose Monitoring System used for?

    The VERI-Q MGD-2001 is designed for self-testing blood glucose levels outside the body. It is intended for individuals with diabetes to monitor their glucose levels at home, helping them manage diabetes control through regular self-monitoring. This allows users to track their blood sugar trends and make informed decisions about their treatment and lifestyle.

  • How is the VERI-Q MGD-2001 Blood Glucose Monitoring System supplied?

    The system is supplied as a reusable monitoring device paired with disposable test strips and lancets. This means the main meter can be reused across multiple testing sessions, while the consumables—test strips and lancets—are single-use items intended for one-time use per test. This design balances convenience with hygiene and cost-effectiveness.

  • Is the VERI-Q MGD-2001 Blood Glucose Monitoring System sterile?

    The available data does not specify whether the device itself is sterile or requires sterilization. However, since it is intended for self-testing at home, the disposable test strips and lancets are likely designed to be sterile for single-use. Users should follow the manufacturer’s instructions for proper handling and disposal to ensure accuracy and safety.

  • Can the VERI-Q MGD-2001 Blood Glucose Monitoring System be reused?

    Yes, the VERI-Q MGD-2001 meter itself is reusable. It is designed to be used repeatedly with compatible disposable test strips and lancets. The reusable nature of the meter helps reduce waste and costs over time, while the single-use consumables ensure each test is accurate and hygienic.

  • What regulatory approval does the VERI-Q MGD-2001 Blood Glucose Monitoring System hold?

    The VERI-Q MGD-2001 Blood Glucose Monitoring System has received FDA 510(k) clearance under product code NBW, classified as a Class II device. This clearance indicates that the device was determined to be substantially equivalent to a predicate device and meets the regulatory requirements for safety and effectiveness as an in vitro diagnostic device.